RECRUITING

The Prevalence of Oral HPV Infection and Oral Lesions in People Living With HIV

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The study will evaluate 300 people living with HIV that attend the Vivent Clinic for HIV care. We will characterize our population and include age, race/ethnicity, sex at birth, tobacco use, alcohol use, other comorbidities, HPV vaccination status, other HPV disease, and lab values such as CD4 count and HIV viral load. We will compare results between participants who are HPV positive and negative. We will also evaluate the relationship between HPV oral infections and lesions and the variables above to better understand possible predictors of HPV infections and lesions.

Official Title

The Prevalence of Oral HPV Infection and Oral Lesions in People Living With HIV in a HIV Primary Care Clinic

Quick Facts

Study Start:2023-04-01
Study Completion:2024-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06205511

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Documented HIV test on any FDA-approved HIV test
  2. 2. Ability and willingness of participant to provide informed consent
  3. 3. Capable of performing an oral swish and spit sample collection
  4. 4. Willingness to have an oral exam by Denver Vivent Health Dentist
  5. 5. Has had at least two visits at the Vivent Health Denver clinic
  6. 6. Study participant allows demographics and medical history/laboratory results in electronic medical records to be confidentially evaluated.
  1. 1. Any medical or mental health diagnosis that the study team concludes would prohibits participation of the protocol
  2. 2. CD4 count \< 200 cells/ml
  3. 3. History of Oral/tongue cancer

Contacts and Locations

Study Contact

Cynthia Firnhaber, MD
CONTACT
3033938050
cynthia.firnhaber@cuanschutz.edu
Billie Thomas
CONTACT
303-393-8050
billie.thomas@viventhealth.org

Study Locations (Sites)

Vivent Health
Denver, Colorado, 80220
United States

Collaborators and Investigators

Sponsor: Vivent Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-04-01
Study Completion Date2024-09

Study Record Updates

Study Start Date2023-04-01
Study Completion Date2024-09

Terms related to this study

Keywords Provided by Researchers

  • HPV
  • HIV
  • SWISH

Additional Relevant MeSH Terms

  • Human Immunodeficiency Virus
  • Human Papilloma Virus